BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26069256)

  • 1. Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells.
    Burton LJ; Smith BA; Smith BN; Loyd Q; Nagappan P; McKeithen D; Wilder CL; Platt MO; Hudson T; Odero-Marah VA
    Carcinogenesis; 2015 Sep; 36(9):1019-27. PubMed ID: 26069256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscadine grape skin extract reverts snail-mediated epithelial mesenchymal transition via superoxide species in human prostate cancer cells.
    Burton LJ; Barnett P; Smith B; Arnold RS; Hudson T; Kundu K; Murthy N; Odero-Marah VA
    BMC Complement Altern Med; 2014 Mar; 14():97. PubMed ID: 24617993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCAAT-displacement protein/cut homeobox transcription factor (CUX1) represses estrogen receptor-alpha (ER-α) in triple-negative breast cancer cells and can be antagonized by muscadine grape skin extract (MSKE).
    Burton LJ; Hawsawi O; Sweeney J; Bowen N; Hudson T; Odero-Marah V
    PLoS One; 2019; 14(4):e0214844. PubMed ID: 30964885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
    Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
    Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-bone microenvironmental interactions promotes STAT3 signaling.
    Henderson VM; Hawsawi O; Burton LJ; Campbell T; Trice K; Dougan J; Howard SM; Odero-Marah VA
    Mol Carcinog; 2019 Aug; 58(8):1349-1361. PubMed ID: 31045290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms.
    Hudson TS; Hartle DK; Hursting SD; Nunez NP; Wang TT; Young HA; Arany P; Green JE
    Cancer Res; 2007 Sep; 67(17):8396-405. PubMed ID: 17804756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscadine Grape Skin Extract Induces an Unfolded Protein Response-Mediated Autophagy in Prostate Cancer Cells: A TMT-Based Quantitative Proteomic Analysis.
    Burton LJ; Rivera M; Hawsawi O; Zou J; Hudson T; Wang G; Zhang Q; Cubano L; Boukli N; Odero-Marah V
    PLoS One; 2016; 11(10):e0164115. PubMed ID: 27755556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
    Tsubaki M; Komai M; Fujimoto S; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
    J Exp Clin Cancer Res; 2013 Sep; 32(1):62. PubMed ID: 24011086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
    Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
    Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
    Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
    Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor‑β‑mediated epithelial‑mesenchymal transition.
    Zhang Q; Han M; Wang W; Song Y; Chen G; Wang Z; Liang Z
    Oncol Rep; 2015 Apr; 33(4):1851-9. PubMed ID: 25632968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells.
    Odero-Marah VA; Wang R; Chu G; Zayzafoon M; Xu J; Shi C; Marshall FF; Zhau HE; Chung LW
    Cell Res; 2008 Aug; 18(8):858-70. PubMed ID: 18645583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phytoalexin camalexin mediates cytotoxicity towards aggressive prostate cancer cells via reactive oxygen species.
    Smith BA; Neal CL; Chetram M; Vo B; Mezencev R; Hinton C; Odero-Marah VA
    J Nat Med; 2013 Jul; 67(3):607-18. PubMed ID: 23179315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the RANK/RANKL signaling with osteoprotegerin prevents castration-induced acceleration of bone metastasis in castration-insensitive prostate cancer.
    Takayama K; Inoue T; Narita S; Maita S; Huang M; Numakura K; Tsuruta H; Saito M; Maeno A; Satoh S; Tsuchiya N; Habuchi T
    Cancer Lett; 2017 Jul; 397():103-110. PubMed ID: 28373003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plumbagin inhibits osteoclastogenesis and reduces human breast cancer-induced osteolytic bone metastasis in mice through suppression of RANKL signaling.
    Sung B; Oyajobi B; Aggarwal BB
    Mol Cancer Ther; 2012 Feb; 11(2):350-9. PubMed ID: 22090419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Epithelial Mesenchymal Transition with prostate and breast health disparities.
    Burton LJ; Hawsawi O; Loyd Q; Henderson V; Howard S; Harlemon M; Ragin C; Roberts R; Bowen N; Gacii A; Odero-Marah V
    PLoS One; 2018; 13(9):e0203855. PubMed ID: 30199553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis.
    Miller RE; Roudier M; Jones J; Armstrong A; Canon J; Dougall WC
    Mol Cancer Ther; 2008 Jul; 7(7):2160-9. PubMed ID: 18606716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3.
    Dey P; Jonsson P; Hartman J; Williams C; Ström A; Gustafsson JÅ
    Mol Endocrinol; 2012 Dec; 26(12):1991-2003. PubMed ID: 23028063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.